These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29971134)

  • 1. Modelling Optimal Control of In-Host HIV Dynamics Using Different Control Strategies.
    Ngina P; Mbogo RW; Luboobi LS
    Comput Math Methods Med; 2018; 2018():9385080. PubMed ID: 29971134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal control in HIV chemotherapy with termination viral load and latent reservoir.
    Olabode D; Rong L; Wang X
    Math Biosci Eng; 2019 Jan; 16(2):619-635. PubMed ID: 30861659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short- and Long-Term Optimal Control of a Mathematical Model for HIV Infection of CD4+T Cells.
    Croicu AM
    Bull Math Biol; 2015 Nov; 77(11):2035-71. PubMed ID: 26493544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 infection dynamics and optimal control with Crowley-Martin function response.
    Naeem Jan M; Ali N; Zaman G; Ahmad I; Shah Z; Kumam P
    Comput Methods Programs Biomed; 2020 Sep; 193():105503. PubMed ID: 32387782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mathematical Model for an Effective Management of HIV Infection.
    Ogunlaran OM; Oukouomi Noutchie SC
    Biomed Res Int; 2016; 2016():4217548. PubMed ID: 27057541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal bang-bang control for variable-order dengue virus; numerical studies.
    Sweilam NH; Al-Mekhlafi SM; Shatta SA
    J Adv Res; 2021 Sep; 32():37-44. PubMed ID: 34484824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Optimal Control to Influenza Pneumonia Coinfection with Antiviral Resistance.
    Kanyiri CW; Luboobi L; Kimathi M
    Comput Math Methods Med; 2020; 2020():5984095. PubMed ID: 32256682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal Control Strategies and Sensitivity Analysis of an HIV/AIDS-Resistant Model with Behavior Change.
    Rabiu M; Willie R; Parumasur N
    Acta Biotheor; 2021 Dec; 69(4):543-589. PubMed ID: 34331152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
    Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
    Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical Analysis of the Effects of HIV-Malaria Co-infection on Workplace Productivity.
    Seidu B; Makinde OD; Seini IY
    Acta Biotheor; 2015 Jun; 63(2):151-82. PubMed ID: 25980477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV viral dynamics.
    Coffin JM
    AIDS; 1996 Dec; 10 Suppl 3():S75-84. PubMed ID: 8970715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal Control and Bifurcation Analysis of HIV Model.
    Cheneke KR
    Comput Math Methods Med; 2023; 2023():4754426. PubMed ID: 36793387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mathematical analysis of antiretroviral therapy aimed at HIV-1 eradication or maintenance of low viral loads.
    Wein LM; D'Amato RM; Perelson AS
    J Theor Biol; 1998 May; 192(1):81-98. PubMed ID: 9628841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of various control strategies to Japanese encephalitic: A mathematical study with human, pig and mosquito.
    De A; Maity K; Jana S; Maiti M
    Math Biosci; 2016 Dec; 282():46-60. PubMed ID: 27702638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal control and cost-effectiveness analysis for the human melioidosis model.
    Engida HA; Gathungu DK; Ferede MM; Belay MA; Kawe PC; Mataru B
    Heliyon; 2024 Feb; 10(4):e26487. PubMed ID: 38434022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV viral load quantification, HIV resistance, and antiretroviral therapy.
    Katzenstein DA; Holodniy M
    AIDS Clin Rev; 1995-1996; ():277-303. PubMed ID: 7488557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A note on the use of optimal control on a discrete time model of influenza dynamics.
    González-Parra PA; Lee S; Velázquez L; Castillo-Chavez C
    Math Biosci Eng; 2011 Jan; 8(1):183-97. PubMed ID: 21361407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Within-host virus models with periodic antiviral therapy.
    De Leenheer P
    Bull Math Biol; 2009 Jan; 71(1):189-210. PubMed ID: 19083064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling and optimal control of pneumonia disease with cost-effective strategies.
    Tilahun GT; Makinde OD; Malonza D
    J Biol Dyn; 2017 Aug; 11(sup2):400-426. PubMed ID: 28613986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.